Table 3.
Total | 24 weeks | 25 weeks | 26 weeks | P value | |
Impairment categorisation at 5.5 years’ CA, N evaluated | 484 | 95 | 145 | 244 | |
None | 46% (41–50) | 40% (28–48) | 42% (34–51) | 51% (44–57) | 0.044* |
Mild | 36% (32–41) | 39% (29–50) | 35% (27–44) | 36% (30–42) | |
Moderate-to-severe | 18% (15–22) | 23% (15–33) | 23% (16–31) | 13% (9–18) | |
Impairment categorisation at 2 years’ CA, N evaluated | 472 | 88 | 143 | 241 | |
None | 61% (57–66) | 53% (43–64) | 60% (52–68) | 65% (59–71) | 0.116* |
Mild | 31% (27–35) | 35% (25–46) | 29% (22–38) | 30% (24–36) | |
Moderate-to-severe | 8% (6–11) | 11% (6–20) | 11% (6–17) | 5% (3–9) |
Of 484 children seen at 5.5 years’ CA, data of 472 children were also available at 2 years’ CA. Results are presented as % (95% CI).
*P value is the result of a χ2 test applied on all three categorical rows of the score. A p value <0.05 is considered significant.
CA, corrected age; GA, gestational age.